Game-Changing Patent: Turbo Energy Unlocks Seamless Solar Storage Integration for Existing Installations – Stock Titan
Game-Changing Patent: Turbo Energy Unlocks Seamless Solar Storage Integration for Existing Installations Stock Titan
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
ZenaTech’s ZenaDrone to File Patent and Accelerate – GlobeNewswire
ZenaTech’s ZenaDrone to File Patent and Accelerate GlobeNewswire
-
In: PATENT NEWS
ZenaTech Accelerates Military-Grade Counter-Drone Defense System Following Biden Executive Order – Stock Titan
ZenaTech Accelerates Military-Grade Counter-Drone Defense System Following Biden Executive Order Stock Titan
-
In: PATENT NEWS
RENA Technologies warns of patent infringement in US, Indian markets – pv magazine International
RENA Technologies warns of patent infringement in US, Indian markets pv magazine International
-
In: PATENT NEWS
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid – WV News
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid WV News
-
In: PATENT NEWS
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid – Longview News-Journal
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid Longview News-Journal
-
In: PATENT NEWS
Yuhan secures US patent for lung cancer drug lazertinib, blocking copycats – koreabiomed.com
Yuhan secures US patent for lung cancer drug lazertinib, blocking copycats koreabiomed.com
-
In: PATENT NEWS
AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036 – GlobeNewswire
AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036 GlobeNewswire
-
In: PATENT NEWS
Europe’s Leading Patent Law Firms — 2025 ranking – Financial Times
Europe’s Leading Patent Law Firms — 2025 ranking Financial Times
-
In: PATENT NEWS
Cyclopharm secures maximum US patent extension for Technegas to 2031 – Biotech Dispatch
Cyclopharm secures maximum US patent extension for Technegas to 2031 Biotech Dispatch